XML 22 R11.htm IDEA: XBRL DOCUMENT v3.20.1
EARNINGS PER SHARE
9 Months Ended
Mar. 31, 2020
Earnings Per Share [Abstract]  
Earnings Per Share [Text Block] Earnings Per Share
Basic net earnings per common share are calculated by dividing Net earnings attributable to Procter & Gamble less preferred dividends by the weighted average number of common shares outstanding during the period. Diluted net earnings per common share are calculated using the treasury stock method, on the basis of the weighted average number of common shares outstanding plus the dilutive effect of stock options and other stock-based awards and the assumed conversion of preferred stock.
Net earnings per share were as follows:
CONSOLIDATED AMOUNTSThree Months Ended March 31Nine Months Ended March 31
2020201920202019
Net earnings$2,957  $2,776  $10,317  $9,203  
Less: Net earnings attributable to noncontrolling interests40  31  90  65  
Net earnings attributable to P&G (Diluted)2,917  2,745  10,227  9,138  
Preferred dividends(64) (64) (193) (195) 
Net earnings attributable to P&G available to common shareholders (Basic)$2,853  $2,681  $10,034  $8,943  
SHARES IN MILLIONS
Basic weighted average common shares outstanding2,476.2  2,509.1  2,489.1  2,501.5  
Add: Effect of dilutive securities
Conversion of preferred shares (1)
85.5  89.6  86.4  90.8  
Impact of stock options and other unvested equity awards (2)
51.6  39.0  54.8  32.0  
Diluted weighted average common shares outstanding2,613.3  2,637.7  2,630.3  2,624.3  
NET EARNINGS PER SHARE (3)
Basic$1.15  $1.07  $4.03  $3.58  
Diluted$1.12  $1.04  $3.89  $3.48  
(1)Despite being included currently in Diluted net earnings per common share, the actual conversion to common stock occurs when the preferred shares are sold. Shares may only be sold after being allocated to the ESOP participants pursuant to the repayment of the ESOP's obligations through 2035.
(2)Weighted average outstanding stock options of approximately 7 million and 4 million for the three months ended March 31, 2020 and 2019, and approximately 3 million and 25 million for the nine months ended March 31, 2020 and 2019 respectively, were not included in the Diluted net earnings per share calculation because the options were out of the money or to do so would have been antidilutive (i.e., the total proceeds upon exercise would have exceeded the market value of the underlying common shares).
(3)Net earnings per share are calculated on Net earnings attributable to Procter & Gamble.